SPRB
Spruce Biosciences, Inc.Company with tickers: SPRB
CIK
1683553
CUSIP
85209E208
Shares Outstanding
2,752,278
13F Activity (30d)
29 filings
27 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $11,987,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $7,575,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-11,987,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-12,266,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-8.94 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-8.94 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |